XML 130 R113.htm IDEA: XBRL DOCUMENT v3.6.0.2
Borrowings - Schedule of Aggregate Long-term Borrowings (Details)
$ in Thousands
Dec. 31, 2016
USD ($)
Debt Instrument [Line Items]  
2017 $ 1,102,653 [1],[2],[3]
2018 331,873 [1],[2],[3]
2019 254,872 [1],[2],[3]
2020 284,750 [1],[2],[3]
2021 0 [1],[2],[3]
There-after 346,878 [1],[2],[3]
Long-term debt, gross 2,321,026
Fair value 2,313,065
Match Funded Liabilties [Member]  
Debt Instrument [Line Items]  
2017 780,997 [1],[2],[3]
2018 265,000 [1],[2],[3]
2019 235,000 [1],[2],[3]
2020 0 [1],[2],[3]
2021 0 [1],[2],[3]
There-after 0 [1],[2],[3]
Long-term debt, gross 1,280,997
Fair value 1,275,059
Other Secured Borrowings [Member]  
Debt Instrument [Line Items]  
2017 321,656 [1],[2],[3]
2018 66,873 [1],[2],[3]
2019 16,750 [1],[2],[3]
2020 284,750 [1],[2],[3]
2021 0 [1],[2],[3]
There-after 0 [1],[2],[3]
Long-term debt, gross 690,029
Fair value 682,703
Senior Notes [Member]  
Debt Instrument [Line Items]  
2017 0 [1],[2],[3]
2018 0 [1],[2],[3]
2019 3,122 [1],[2],[3]
2020 0 [1],[2],[3]
2021 0 [1],[2],[3]
There-after 346,878 [1],[2],[3]
Long-term debt, gross 350,000
Fair value $ 355,303
[1] Amounts are exclusive of any related discount or unamortized debt issuance costs.
[2] Excludes financing liabilities, which we recognized in connection with asset sales transactions that we accounted for as financings. Financing liabilities include $477.7 million recorded in connection with sales of Rights to MSRs and $3.4 billion recorded in connection with the securitizations of HMBS. The MSR-related financing liabilities have no contractual maturity and are amortized over the life of the transferred Rights to MSRs. The HMBS-related financing liabilities have no contractual maturity and are amortized as the related loans are repaid.
[3] For match funded liabilities, the expected maturity date is the date on which the revolving period ends for each advance financing facility note and repayment of the outstanding balance must begin if the note is not renewed or extended.